Status:
COMPLETED
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
Lead Sponsor:
Shire
Conditions:
Essential Thrombocythemia (ET)
Eligibility:
All Genders
6-17 years
Brief Summary
The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment opt...
Eligibility Criteria
Inclusion
- \- 6 years or over and less than 18 years patient has ET according to the WHO criteria as guidance
Exclusion
- Interventional clinical study participation
Key Trial Info
Start Date :
September 28 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01198717
Start Date
September 28 2010
End Date
March 1 2016
Last Update
March 17 2021
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Paediatric Clinic University Hospital Olomouc
Olomouc, Czechia, 77520
2
Clinic of Paediatric haematology and oncology University Hospital Motol
Prague, Czechia
3
Paediatric Oncology Unit, Hopital Cote De Nacre
Caen, France, 14033
4
Practicen Hospitalier , Institute d'Hematologie et Oncologie Pediatrique
Lyon, France, 69008